Received: 16 November 2018
Accepted: 25 December 2018
First Online: 31 January 2019
Ethics approval and consent to participate
: The two IRB approvals for bronchiectasis and CF are the number #660, October 14th, 2014, and the 594_2016 bis, October 11th, 2016, respectively; both of them granted from the Ethical Committee Milano Area B. Written consent for the use of both clinical and biological data has been given by enrolled patients and following Hospital IRB approval.
: Not applicable.
: The authors declare that they have no competing interests. FB is Editor-in-Chief of Multidisciplinary Respiratory Medicine, whereas SA is Associate Editor of Multidisciplinary Respiratory Medicine.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.